As the CD28/B7 co-stimulatory pathway is crucial for effective therapy with PD-1 blockade, IL PV-10 may enhance the ability of DC to stimulate tumor-reactive T cells at the tumor site [20, 21]. Here, PDCD1 is linked to neoplasm.